Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
European Journal of Applied Physiology|September 20, 2011
Skeletal muscle signaling response to sprint exercise in men and womenTeresa Fuentes, Borja Guerra, Jesús G Ponce-González, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 1, 2022
SOCS2 protects against chemical-induced hepatocellular carcinoma progression by modulating inflammation and cell proliferation in the liverJuan José Cabrera-Galván, Eduardo Araujo, Mercedes de Mirecki-Garrido, et al.
British Journal of Sports Medicine|July 21, 2009
Androgen receptor gene polymorphisms lean mass and performance in young menAmelia Guadalupe-Grau, F Germán Rodríguez-González, Cecilia Dorado, et al.
Diabetes|March 10, 2012
GLUT4 and glycogen synthase are key players in bed rest-induced insulin resistanceRasmus S Biensø, Stine Ringholm, Kristian Kiilerich, et al.
Oncotarget|August 25, 2016
CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemiaBorja Guerra, Patricia Martín-Rodríguez, Juan Carlos Díaz-Chico, et al.
Oncotarget|September 6, 2018
Correction: CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemiaBorja Guerra, Patricia Martín-Rodríguez, Juan Carlos Díaz-Chico, et al.
International Journal of Biological Sciences|April 17, 2023
Chemical-proteomics Identify Peroxiredoxin-1 as an Actionable Target in Triple-negative Breast CancerElena Spínola-Lasso, Juan Carlos Montero, Roberto Jiménez-Monzón, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 21, 2021
JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemiaHaidée Aranda-Tavío, Carlota Recio, Pedro Martín-Acosta, et al.
Cellular and Molecular Life Sciences : CMLS|July 6, 2024
Endogenous LXR signaling controls pulmonary surfactant homeostasis and prevents lung inflammationIrene Hernández-Hernández, Juan V De La Rosa, Patricia Martín-Rodríguez, et al.
Pageof 4